DHN unveils landmark Annual Digital Health Trends & Outlook 2025 Report at its Delhi Forum; AI emerges as top priority: Our ...

US FDA clears YolTech’s IND application for YOLT-101, an in vivo base editing therapy to treat heterozygous familial hypercholesterolemia: Shanghai, China Monday, June 9, 2025, ...

CK Birla Hospital strengthens robotic orthopaedics programme amid rising burden of joint issues in India: Our Bureau, Bengaluru Monday, June 9, 2025, 16:45 Hrs [IST] CK Birla Hosp ...

Mediar Therapeutics doses first patient in phase 2 WISPer trial of MTX-463 for idiopathic pulmonary fibrosis: Boston Monday, June 9, 2025, 15:00 Hrs [IST] Mediar Therapeutics, Inc ...

Lupus Foundation of America awards summer fellowship grants to seven young scientists advancing lupus research: Washington, DC Monday, June 9, 2025, 16:00 Hrs [IST] The Lupus Foun ...

Sharda Care Healthcity appoints Dr Atampreet Singh as its senior director & head: Our Bureau, Bengaluru Monday, June 9, 2025, 14:45 Hrs [IST] Sharda Care Healthcity has appointed ...

Glenmark Pharma to launch DCGI-approved Brukinsa in India to advance treatment of haematological malignancies: Our Bureau, Mumbai Monday, June 9, 2025, 14:30 Hrs [IST] Glenmark Ph ...

Telix’s Illuccix PSMA-PET imaging agent receives German approval: Melbourne, Australia Monday, June 9, 2025, 14:00 Hrs [IST] Telix announces that its prostate cancer PET imaging ...

New artificial intelligence-powered service launched to transform cancer detection and care: United Kingdom Monday, June 9, 2025, 13:00 Hrs [IST] A new artificial intelligence (AI ...

Alcon introduces PRECISION1, next-generation daily disposable contact lenses, in India: Our Bureau, Mumbai Monday, June 9, ...

EMA’s safety committee concludes eye condition NAION is a very rare side effect of semaglutide medicines Ozempic, Rybelsus & Wegovy: Amsterdam, The Netherlands Monday, June 9, 2 ...

Lupin receives US FDA tentative approval for oxcarbazepine ER tablets: Our Bureau, Mumbai Monday, June 9, 2025, 11:45 Hrs [IST] Global pharma major Lupin Limited (Lupin) announced ...